Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
‘Real life’ effectiviteit en veiligheid van SOF/VEL/VOX bij HCV na falen op DAA
nov 2019 | Hepatitis